BSE Live
Dec 31, 16:01Prev. Close
72.60
Open Price
72.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:40Prev. Close
72.44
Open Price
72.44
Bid Price (Qty.)
73.32 (20)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 4.89 | 6.72 | 3.90 | 5.79 | 6.41 | |
| Diluted EPS (Rs.) | 4.89 | 6.75 | 3.94 | 5.79 | 6.41 | |
| Cash EPS (Rs.) | 10.96 | 11.85 | 8.67 | 10.67 | 11.03 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 62.07 | 66.81 | 61.21 | 58.91 | 53.51 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 62.07 | 66.81 | 61.21 | 58.91 | 53.51 | |
| Dividend / Share(Rs.) | 1.20 | 1.20 | 1.00 | 1.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 190.00 | 214.21 | 193.18 | 189.15 | 168.20 | |
| PBDIT/Share (Rs.) | 20.24 | 22.65 | 17.96 | 20.03 | 19.57 | |
| PBIT/Share (Rs.) | 14.18 | 17.30 | 13.20 | 15.15 | 14.68 | |
| PBT/Share (Rs.) | 3.60 | 7.66 | 5.45 | 8.13 | 6.61 | |
| Net Profit/Share (Rs.) | 4.90 | 6.50 | 3.90 | 5.79 | 6.14 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 10.65 | 10.57 | 9.29 | 10.59 | 11.63 | |
| PBIT Margin (%) | 7.46 | 8.07 | 6.83 | 8.00 | 8.72 | |
| PBT Margin (%) | 1.89 | 3.57 | 2.82 | 4.30 | 3.92 | |
| Net Profit Margin (%) | 2.57 | 3.03 | 2.02 | 3.05 | 3.64 | |
| Return on Networth / Equity (%) | 7.89 | 9.72 | 6.37 | 9.82 | 11.46 | |
| Return on Capital Employed (%) | 16.46 | 17.97 | 15.27 | 17.95 | 18.97 | |
| Return on Assets (%) | 2.22 | 2.84 | 1.76 | 2.96 | 3.47 | |
| Total Debt/Equity (X) | 1.46 | 1.27 | 1.30 | 1.12 | 1.25 | |
| Asset Turnover Ratio (%) | 0.85 | 0.95 | 0.95 | 1.02 | 1.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.16 | 1.34 | 1.27 | 1.34 | 1.32 | |
| Quick Ratio (X) | 0.68 | 0.93 | 0.81 | 0.89 | 0.91 | |
| Inventory Turnover Ratio (X) | 3.18 | 1.96 | 2.06 | 2.43 | 2.12 | |
| Dividend Payout Ratio (NP) (%) | 24.49 | 15.27 | 25.41 | 17.27 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 10.94 | 8.37 | 11.44 | 9.37 | 0.00 | |
| Earnings Retention Ratio (%) | 75.51 | 84.73 | 74.59 | 82.73 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 89.06 | 91.63 | 88.56 | 90.63 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 269.07 | 264.91 | 222.89 | 252.77 | 174.94 | |
| EV/Net Operating Revenue (X) | 0.89 | 0.78 | 0.74 | 0.90 | 0.70 | |
| EV/EBITDA (X) | 8.35 | 7.40 | 7.91 | 8.51 | 6.03 | |
| MarketCap/Net Operating Revenue (X) | 0.44 | 0.43 | 0.35 | 0.57 | 0.32 | |
| Retention Ratios (%) | 75.50 | 84.72 | 74.58 | 82.72 | 0.00 | |
| Price/BV (X) | 1.34 | 1.37 | 1.09 | 1.83 | 1.00 | |
| Price/Net Operating Revenue | 0.44 | 0.43 | 0.35 | 0.57 | 0.32 | |
| Earnings Yield | 0.06 | 0.07 | 0.06 | 0.05 | 0.11 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y